FA
OGN icon

Financial Advantage’s Organon & Co OGN Stock Holding History

Financial Advantage’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$3K – 136
2022
Q1 		$3K Buy
100
+98
+4,900% +$3.35K ﹤0.01% 134
2021
Q4 		$0 Hold
2
– – ﹤0.01% 131
2021
Q3 		$0 Hold
2
– – ﹤0.01% 118
2021
Q2 		$0 Buy
+2
New +$66 ﹤0.01% 121

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Financial Advantage's OGN Position: Q2 2022 in Review

Financial Advantage sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 100 shares — an estimated $3K sold.

Financial Advantage first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Financial Advantage reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Financial Advantage sold 100 Organon & Co shares in Q2 2022, an estimated $3K.
  • Financial Advantage first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Financial Advantage's Organon & Co position peaked at $3K in Q1 2022.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Financial Advantage's 13F filing for Q2 2022, filed 1 Aug 2022.